Shallow Whole-Genome Sequencing of Cell-Free DNA (cfDNA) Detects Epithelial Ovarian Cancer and Predicts Patient Prognosis

Shallow Whole-Genome Sequencing of Cell-Free DNA (cfDNA) Detects Epithelial Ovarian Cancer and Predicts Patient Prognosis

Despite the progress in diagnostics and therapeutics, epithelial ovarian cancer (EOC) remains a fatal disease. Using shallow whole-genome sequencing of plasma cell-free DNA (cfDNA), we investigated biomarkers that could detect EOC and predict survival. Plasma cfDNA from 40 EOC patients and 20 health...

Full description

Bibliographic Details
Main Authors:	Seong Eun Bak, Hanwool Kim, Jung Yoon Ho, Eun-Hae Cho, Junnam Lee, Sung Min Youn, Seong-Woo Park, Mi-Ryung Han, Soo Young Hur, Sung Jong Lee, Youn Jin Choi
Format:	Article
Language:	English
Published:	MDPI AG 2023-01-01
Series:	Cancers
Subjects:	cfDNA epithelial ovarian cancer shallow whole-genome sequencing plasma prognosis
Online Access:	https://www.mdpi.com/2072-6694/15/2/530

Similar Items

The cfDNA in early cancer detection
by: Hussein Adil Abid, et al.
Published: (2024-01-01)

Deep cfDNA fragment end profiling enables cancer detection
by: Yulia V. Zhitnyuk, et al.
Published: (2022-01-01)

Using cfDNA and ctDNA as Oncologic Markers: A Path to Clinical Validation
by: Jonathan Dao, et al.
Published: (2023-08-01)

What fraction of cellular DNA turnover becomes cfDNA?
by: Ron Sender, et al.
Published: (2024-02-01)

cfDNA Methylation Profiles and T-Cell Differentiation in Women with Endometrial Polyps
by: Xiao-Hong Li, et al.
Published: (2022-12-01)

cfDNA Changes in Maximal Exercises as a Sport Adaptation Predictor
by: Kinga Humińska-Lisowska, et al.
Published: (2021-08-01)

Methylation pattern of caveolin-1 in prostate cancer as potential cfDNA biomarker
by: Lucija Škara, et al.
Published: (2023-01-01)

Dynamics of Specific cfDNA Fragments in the Plasma of Full Marathon Participants
by: Takehito Sugasawa, et al.
Published: (2021-04-01)

Effect of acute moderate-intensity cycling on cfDNA levels considering menstrual cycle phases
by: Akemi Sawai, et al.
Published: (2024-01-01)

Unlocking the secrets: the power of methylation-based cfDNA detection of tissue damage in organ systems
by: Lijing Zhang, et al.
Published: (2023-10-01)

Microfluidic Technologies for cfDNA Isolation and Analysis
by: Zheyun Xu, et al.
Published: (2019-10-01)

Plasma cell-free DNA (cfDNA) as a predictive and prognostic marker in patients with metastatic breast cancer
by: Daniel Fernandez-Garcia, et al.
Published: (2019-12-01)

Identification of osimertinib-resistant EGFR L792 mutations by cfDNA sequencing: oncogenic activity assessment and prevalence in large cfDNA cohort
by: Stephen R. Fairclough, et al.
Published: (2019-10-01)

Extracellular Vesicle-Derived DNA vs. CfDNA as a Biomarker for the Detection of Colon Cancer
by: Kavita Thakur, et al.
Published: (2021-07-01)

Liver Transplantation and dd-cfDNA: A Small Solution for a Big Problem
by: Eleni Avramidou, et al.
Published: (2023-02-01)

Results of a worldwide external quality assessment of cfDNA testing in lung Cancer
by: Jennifer A. Fairley, et al.
Published: (2022-07-01)

Assessment of Donor Derived Cell Free DNA (dd-cfDNA) at Surveillance and at Clinical Suspicion of Acute Rejection in Renal Transplantation
by: Evangelos Mantios, et al.
Published: (2023-10-01)

Can Liquid Biopsy Based on ctDNA/cfDNA Replace Tissue Biopsy for the Precision Treatment of EGFR-Mutated NSCLC?
by: Yi-Ze Li, et al.
Published: (2023-02-01)

Utility of cfDNA Fragmentation Patterns in Designing the Liquid Biopsy Profiling Panels to Improve Their Sensitivity
by: Maxim Ivanov, et al.
Published: (2019-03-01)

Quantification of mitochondrial cfDNA reveals new perspectives for early diagnosis of colorectal cancer
by: Christian Linke, et al.
Published: (2023-03-01)

Beyond the Blood: CSF-Derived cfDNA for Diagnosis and Characterization of CNS Tumors
by: Abbye E. McEwen, et al.
Published: (2020-02-01)

Impact of cfDNA Reference Materials on Clinical Performance of Liquid Biopsy NGS Assays
by: Ariane Hallermayr, et al.
Published: (2023-10-01)

Investigation of Different Library Preparation and Tissue of Origin Deconvolution Methods for Urine and Plasma cfDNA Methylome Analysis
by: Nicholas Kueng, et al.
Published: (2023-07-01)

Detection of neuron-derived cfDNA in blood plasma: a new diagnostic approach for neurodegenerative conditions
by: Chad Pollard, et al.
Published: (2023-10-01)

Accuracy of analysis of cfDNA for detection of single nucleotide variants and copy number variants in breast cancer
by: Xin Yang, et al.
Published: (2019-05-01)

Technical Evaluation of the COBAS EGFR Semiquantitative Index (SQI) for Plasma cfDNA Testing in NSCLC Patients with EGFR Exon 19 Deletions
by: José Manuel González de Aledo-Castillo, et al.
Published: (2021-07-01)

Prediction of methylation status using WGS data of plasma cfDNA for multi-cancer early detection (MCED)
by: Pin Cui, et al.
Published: (2024-02-01)

Isolation of cfDNA from spent culture media and its association with implantation rate and maternal immunomodulation
by: Amin Alizadegan, et al.
Published: (2022-07-01)

Diagnostic Value of cfDNA in Pancreatic Cancer
by: XU Yijun, et al.
Published: (2022-12-01)

Use of Enzymatically Converted Cell-Free DNA (cfDNA) Data for Copy Number Variation-Linked Fragmentation Analysis Allows for Early Colorectal Cancer Detection
by: Iva Černoša, et al.
Published: (2024-03-01)

cfDNA in pancreatic neuroendocrine carcinoma management with Cushing’s syndrome
by: Laura Gerard, et al.
Published: (2023-01-01)

Preoperative Mutational Analysis of Circulating Tumor Cells (CTCs) and Plasma-cfDNA Provides Complementary Information for Early Prediction of Relapse: A Pilot Study in Early-Stage Non-Small Cell Lung Cancer
by: A. N. Markou, et al.
Published: (2023-03-01)

Regulation of Cathelicidin Antimicrobial Peptide (CAMP) Gene Expression by TNFα and cfDNA in Adipocytes
by: Alexandra Höpfinger, et al.
Published: (2023-10-01)

Fragmentomic cfDNA Patterns in Noninvasive Prenatal Testing and Beyond
by: Kavish Kohabir, et al.
Published: (2021-04-01)

Donor-Derived Cell-Free DNA (dd-cfDNA) in Kidney Transplant Recipients With Indication Biopsy—Results of a Prospective Single-Center Trial
by: Louise Benning, et al.
Published: (2023-11-01)

Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective Study
by: Valerio Gristina, et al.
Published: (2022-12-01)

Integrating cfDNA liquid biopsy and organoid-based drug screening reveals PI3K signaling as a promising therapeutic target in colorectal cancer
by: Huan Yang, et al.
Published: (2024-02-01)

Graft-Derived Cell-Free DNA Quantification following Liver Transplantation Using Tissue-Specific DNA Methylation and Donor-Specific Genotyping Techniques: An Orthogonal Comparison Study
by: Daniel R. A. Cox, et al.
Published: (2023-06-01)

Plasma cfDNA as a Potential Biomarker to Evaluate the Efficacy of Chemotherapy in Gastric Cancer
by: Zhong Y, et al.
Published: (2020-05-01)

Laboratory performance of genome-wide cfDNA for copy number variants as compared to prenatal microarray
by: Erica Soster, et al.
Published: (2023-06-01)